D. Tuffin

发表

(2,6-Dimethylphenylsulphonyl)nitromethane: a new structural type of aldose reductase inhibitor which follows biphasic kinetics and uses an allosteric binding site.

W. Ward, R. Howe, F. Carey, 1991, Biochemical pharmacology.

The effect of thromboxane A2 synthesis inhibitors on platelet aggregation in whole blood.

D. Lunt, D. Tuffin, N. Lad, 1987, Thrombosis research.

Calcium channel blocking drugs: A structural lead for PAF antagonists?

D. Tuffin, P. J. Wade, 1985 .

Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo

A. Honey, D. Tuffin, R. Booth, 1989, British journal of pharmacology.

Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human platelets.

D. Lunt, R. Dyer, P. Davey, 1985, Advances in experimental medicine and biology.

Interaction of Paf-Acether with the Human Platelet: Receptor Binding and Pharmacology

D. Tuffin, P. J. Wade, 1987 .

Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets.

D. Lunt, K. McCullagh, D. Tuffin, 1986, Thrombosis research.

Identification of small peptide analogues having agonist and antagonist activity at the platelet thrombin receptor.

P. Manley, M. Scrutton, D. Tuffin, 1988, Biochemical pharmacology.

5-[6-1 -(Cyclohexyl-1 H-tetrazol-5-YL)hexyl]-1,8-naphthyridin-2-(1H)-one, SC-44368, a Potent Anti-aggregatory Agent which Selectively Inhibits Platelet Cyclic AMP Phosphodiesterase.

P. Manley, S. Oswald, D. Lunt, 1992, Platelets.

The action of polyanionic agents defibrotide and pentosan sulphate on fibrinolytic activity in the laboratory rat

P. Alcock, A. Jamieson, D. Tuffin, 1996 .

Effect of Indomethacin and Dazoxiben on Intravascular Platelet Aggregation in the Anaesthetized Rabbit

A. Honey, D. Tuffin, N. Lad, 1986, Thrombosis and Haemostasis.

The Effect of Interleukin-4 on Tumour Necrosis Factor-Alpha Induced Expression of Tissue Factor and Plasminogen Activator Inhibitor-1 in Human Umbilical Vein Endothelial Cells

A. Jamieson, D. Tuffin, N. B. Martin, 1993, Thrombosis and Haemostasis.

Kinetic characteristics of ZENECA ZD5522, a potent inhibitor of human and bovine lens aldose reductase.

W. Ward, R. Howe, F. Carey, 1995, Biochemical pharmacology.

Pharmacological effects of (+/-)-11-deoxy, 16-phenoxy-prostaglandin E1 derivatives in the cardiovascular system.

A. K. Banerjee, D. Tuffin, J. L. Walker, 1985, British journal of pharmacology.

Thromboxane synthase inhibitors. Synthesis and pharmacological activity of (R)-, (S)-, and (+/-)-2,2-dimethyl-6-[2-(1H-imidazol-1-yl)-1-[[(4-methoxyphenyl)- methoxy]methyl]ethoxy]hexanoic acids.

P. Manley, P. Buckle, D. Lunt, 1987, Journal of medicinal chemistry.

Effect of SC 38249, a Novel Substituted Imidazole, on Platelet Aggregation In Vitro and In Vivo

J. Westwick, P. Manley, D. Lunt, 1988, Thrombosis and Haemostasis.

A comparison of fibrinolytic capacity and response to TNF-α stimulation in the cultured endothelial cell lines ECV 304 and EA.hy 926

H. Rutter, A. Jamieson, D. Tuffin, 1994 .

Thrombin receptor antagonists. Structure-activity relationships for the platelet thrombin receptor and effects on prostacyclin synthesis by human umbilical vein endothelial cells.

P. Manley, M. Scrutton, D. Tuffin, 1990, Biochemical pharmacology.

Structure-activity relationships in an imidazole-based series of thromboxane synthase inhibitors.

P. Manley, P. Buckle, D. Lunt, 1987, Journal of medicinal chemistry.

Whole-blood assays for evaluation of thromboxane synthase inhibition.

G. Walsh, O. D. Suleymanov, D. Tuffin, 1999, Methods in molecular biology.